Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.
University of Tennessee Health Science Center, Memphis, Tennessee; American Gastroenterological Association Institute, Center for Diagnostics and Therapeutics, Bethesda, Maryland.
Colin W
CW
Howden
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; American Gastroenterological Association Institute, Center for Diagnostics and Therapeutics, Bethesda, Maryland.
Nimish B
NB
Vakil
D000818:Animals; D035843:Biomedical Research; D055808:Drug Discovery; D004415:Dyspepsia / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D057765:Eosinophilic Esophagitis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D005762:Gastroenterology; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005769:Gastrointestinal Motility / Q000187:drug effects; D018589:Gastroparesis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D041742:Upper Gastrointestinal Tract / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology
D005765:Gastrointestinal Agents; D054328:Proton Pump Inhibitors